Raloxifene/SBE-β-CD Inclusion Complexes Formulated into Nanoparticles with Chitosan to Overcome the Absorption Barrier for Bioavailability Enhancement

Raloxifene (RXF) is a hormone-like medication used for treating postmenopausal osteoporosis and estrogen-dependent breast cancer, yet associated with bad low bioavailability due to poor solubility. This study was intended to develop cyclodextrin/chitosan nanoparticles (ccNPs) for oral delivery of RX...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zaihua, Li, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160996/
https://www.ncbi.nlm.nih.gov/pubmed/29958389
http://dx.doi.org/10.3390/pharmaceutics10030076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160996/
https://www.ncbi.nlm.nih.gov/pubmed/29958389
http://dx.doi.org/10.3390/pharmaceutics10030076

Ejemplares similares